We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more,点击这里. By continuing to use our site, you accept our use of cookies.
Eurofins Technologies是Eurofins Scientific Group的一部分，是一家快速增长的全球诊断测试套件和实验室消耗品的提供商，该领域是食品，饲料，环境，生物制药和临床行业的生物分析测试领域。The company offers a broad range of product test kits for Pathogens...
The CE-marked GSD NovaPrime Plus SARS-CoV-2 is a new Multiplex Real-Time RT-PCR assay intended for the qualitative detection of SARS-CoV-2 and the simultaneous discrimination of B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.1.248 (P.1) (Gamma) lineages in one reaction.
The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
The INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The dual recognition enzyme-linked immunosorbent assay (ELISA) capable of detecting semi-quantitatively total SARS-CoV-2 virus N-protein-specific antibodies (IgG, IgM and IgA) in a single human serum or plasma sample.
The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
Eurofins Scientific (Ebersberg, Germany) has announces that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (DDC; Fairfield, OH, USA).
• Separate Detection of IgG antibodies • SARS-CoV-2 Nucleocapsid recombinant antigen • Ideal complement to RT-PCR • Ready-to-use controls • Results in 2 hours • Assay procedure is easy to automate •在任何开放的ELISA系统（可用协议）上工作 • CE-IVDRequest Information
